Novartis

The companies will be looking at the real-world data from treatment with BRAF and MEK inhibitors. 

The initiative will support the NHS in its recovery as it navigates the COVID-19 pandemic.

The results will not impact the current rollout of a new version of the app, under special FDA guidelines.

It's been quite a year for digital, from Akili's de novo clearance to the downfall of 'digital pill' maker Proteus. MobiHealthNews takes a look back at the highlights. 

The tool was designed to help patients and caregivers manage the condition and treatment. 

At a recent online event, Novartis Chief Digital Officer Betrand Bodson gave an update on a digital strategy that began in 2018.

The new expansion is linked to a partnership the digital health company has with Novartis. 

This week's top stories include primary care doctors saying they're not ready for the next COVID-19 surge, Philips building out the VA's telehealth infrastructure, and Novartis and Propeller Health co-packaging a new asthma treatment.

The co-packaged product, which will be launched in Europe this year, combines Propeller's sensor tech and Novartis' new medication. 

Also: TapestryHealth purchases its telehealth tech vendor; Tech professionals eyeing healthcare and pharma jobs with new interest after COVID-19.